| Execution period | FY 2026-27 |
|---|
BSE filing, NSE: ANUHPHR. Summary written from the filing by ALFA Finder's alert engine.
Anuh Pharma Ltd: key numbers
- Share price
- ₹79.90
- Market cap
- ₹800.8 Cr
- Revenue (annual)
- ₹771.7 Cr
- Net profit (annual)
- ₹41.05 Cr
- P/E (TTM)
- 18.1×Sector 46.1×
- Promoter holding
- 71.80%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anuh Pharma Ltd
All →Anuh Pharma Board Meeting Date
Anuh Pharma's board meets on 30 October 2026 to approve Q1/H1 FY27 results. Trading window closed for insiders until 1 November 2026.
Anuh Pharma Acquisition Worth ₹72.9 Cr
Anuh Pharma signed an Asset Transfer Agreement to acquire a manufacturing facility from Vanquest Pharma for ₹72.90 Crore, increasing its production capacity by 525 MTPA.
- Value
- ₹72.90 Cr
- manufacturing capacity
- 525.0 MTPA
Anuh Pharma Debt & Borrowing: ₹75 Cr
Anuh Pharma Ltd board approved a loan of ₹75 Crore to finance manufacturing asset investments for expanding production capacity.
- Value
- ₹75.00 Cr
Anuh Pharma Other Announcement
Anuh Pharma Ltd filed the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as issued by its RTA.
Anuh Pharma Legal & Regulatory
Anuh Pharma disclosed a Rs. 9,93,206 tax demand under Section 156, Income Tax Act, for AY 2018-19. The company plans to appeal before the CIT.
- Value
- ₹0.10 Cr
Anuh Pharma Investor Presentation: Key Takeaways
Anuh Pharma reported strong Q1 FY27 results with 4% YoY revenue growth and 38% PAT growth, driven by a shift to high-value regulated markets.
- Call
- Guides 18% growth
Other debt & borrowing announcements
All →Samvardhana Motherson International Debt & Borrowing: ₹834.8 Cr
Samvardhana Motherson issued a corporate guarantee for a EUR 75 million BNP Paribas term facility of subsidiary MGI B.V. Liability capped at ₹834.75 Crore.
- Value
- ₹834.8 Cr
- Execution
- Guarantee valid up to February 28, 2032
Electrotherm (India) Debt & Borrowing: ₹59.81 Cr
Electrotherm disclosed a Rs 59.81 Crore default on bank loans as at 30 September 2026. The loans were assigned to an ARC under a settlement.
- Value
- ₹59.81 Cr
Shree Renuka Sugars Debt & Borrowing: ₹1.55 Cr
Shree Renuka Sugars paid monthly interest on four listed NCD series on October 29, 2026. Total interest paid across the series is Rs. 1.58 Crore.
- Value
- ₹1.55 Cr
Avenue Supermarts Debt & Borrowing: ₹200 Cr
Avenue Supermarts allotted Rs 200 crore of unsecured commercial paper on 29 October 2026, maturing 11 December 2026 at 7.20% coupon. The paper carries an ICRA A1+ rating and is proposed to be listed on BSE.
- Value
- ₹200.0 Cr
- Execution
- 43 days
Aye Finance Debt & Borrowing: ₹1.76 Cr
Aye Finance paid Rs.1.76 Crore monthly interest on its 9.75% secured NCDs on the due date, with no delay. Payment was made on time, matching the scheduled amount.
- Value
- ₹1.76 Cr
IndusInd Bank Debt & Borrowing: ₹227.1 Cr
IndusInd Bank certified payment of Rs.227.08 crore interest on its Tier 2 Bonds (ISIN INE095A08090) on the due date of 29 October 2026. This is a Regulation 57 debt servicing confirmation.
- Value
- ₹227.1 Cr